CL
CL.US Colgate-Palmolive Company
- Market cap
- USD 79.2B
- P/E
- 38.0x
- P/B
- 270.22x
- ROE
- 967.6%
- Dividend yield
- 2.30%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CL.US undervalued?
Graham numberThe Graham number of Colgate-Palmolive Company cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Colgate-Palmolive Company fundamental analysis
No fundamental analysis for Colgate-Palmolive Company yet.
Colgate-Palmolive Company stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, househ…
Full company profileColgate-Palmolive Company financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Colgate-Palmolive Company annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.2B | 15.5B | 15.5B | 15.7B | 16.5B | 17.4B | 18.0B | 19.5B | 20.1B | 20.4B | 21.4B |
| Gross Profit | 9.13B | 9.32B | 9.21B | 9.28B | 9.93B | 10.3B | 10.2B | 11.3B | 12.1B | 12.3B | 13.0B |
| Operating Income | 3.96B | 4.01B | 3.85B | 3.76B | 3.91B | 3.89B | 3.59B | 4.13B | 4.38B | 3.31B | 4.39B |
| EBITDA | 4.33B | 4.12B | 4.17B | 4.01B | 4.35B | 3.76B | 3.37B | 4.25B | 4.85B | 4.87B | 4.69B |
| Net Income | 2.44B | 2.02B | 2.40B | 2.37B | 2.70B | 2.17B | 1.79B | 2.30B | 2.89B | 2.13B | 2.79B |
| EPS | 2.72 | 2.28 | 2.75 | 2.75 | 3.14 | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 | 3.49 |
| Balance Sheet | |||||||||||
| Total Assets | 12.1B | 12.7B | 12.2B | 15.0B | 15.9B | 15.0B | 15.7B | 16.4B | 16.0B | 16.3B | 16.7B |
| Total Liabilities | 12.1B | 12.4B | 12.0B | 14.5B | 14.8B | 14.1B | 14.9B | 15.4B | 15.5B | 16.0B | 16.1B |
| Shareholders' Equity | 17.0M | 243M | 197M | 558M | 1.10B | 971M | 806M | 957M | 544M | 365M | 288M |
| Cash & Short-term Investments | 1.32B | 1.54B | 726M | 883M | 888M | 832M | 775M | 966M | 1.26B | 1.29B | 1.53B |
| Total Debt | 6.53B | 6.58B | 6.37B | 15.2B | 7.74B | 7.43B | 9.27B | 9.06B | 8.51B | 8.55B | 7.72B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.14B | 3.05B | 3.06B | 3.13B | 3.72B | 3.33B | 2.56B | 3.75B | 4.11B | 4.20B | 3.88B |
| Capital Expenditure | 593M | 553M | 436M | 335M | 410M | 567M | 696M | 705M | 561M | 564M | 533M |
| Free Cash Flow | 2.55B | 2.50B | 2.62B | 2.80B | 3.31B | 2.76B | 1.86B | 3.04B | 3.55B | 3.63B | 3.35B |
| Ratios | |||||||||||
| ROE | 14,358.8% | 832.9% | 1,218.3% | 424.2% | 244.8% | 223.1% | 221.5% | 240.3% | 531.1% | 584.1% | 967.6% |
| ROA | 20.1% | 16.0% | 19.7% | 15.7% | 16.9% | 14.4% | 11.3% | 14.0% | 18.0% | 13.1% | 16.6% |
| Net Profit Margin | 16.1% | 13.1% | 15.4% | 15.1% | 16.4% | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% | 13.0% |
| Debt to Equity | 384.29x | 27.07x | 32.31x | 27.20x | 7.03x | 7.65x | 11.50x | 9.47x | 15.65x | 23.44x | 26.79x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Colgate-Palmolive Company dividends
- Dividend yield
- 2.30%
- Forward dividend
- 2.12 USD
- Payout ratio
- 85.5%
- Ex-dividend date
- Oct 20, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.82B | 2.25 | 85.5% |
| 2024 | USD 1.79B | 2.18 | 61.9% |
| 2023 | USD 1.75B | 2.11 | 76.0% |
| 2022 | USD 1.69B | 2.02 | 94.7% |
| 2021 | USD 1.68B | 1.98 | 77.5% |
| 2020 | USD 1.65B | 1.92 | 61.4% |
| 2019 | USD 1.61B | 1.87 | 68.2% |
| 2018 | USD 1.59B | 1.82 | 66.3% |
| 2017 | USD 1.53B | 1.72 | 75.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on May 16, 2013.
Who owns Colgate-Palmolive Company
- Insiders 0.15%
- Institutions 87.46%
- Public & others 12.39%
- Shares outstanding 795M
- Free float 746M
Top funds holding CL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 25.3M | 3.18% | -0.63% | Sep 2026 |
| Vanguard 500 Index Investor | 20.9M | 2.63% | -1.50% | Sep 2026 |
| iShares Core S&P 500 ETF | 10.6M | 1.34% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 10.4M | 1.30% | -0.26% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 9.72M | 1.22% | -0.25% | Oct 2026 |
| Vanguard MStar Mid Cap Index Instl | 8.54M | 1.07% | 0.00% | Sep 2026 |
| Vanguard MStar Value Index Investor | 7.59M | 0.96% | -0.82% | Sep 2026 |
| State Street®CnsmrStpSelSectSPDR®ETF | 6.98M | 0.88% | +0.12% | Oct 2026 |
| First Eagle Global A | 5.34M | 0.67% | 0.00% | Sep 2026 |
| Vanguard Dividend Appreciation ETF | 4.51M | 0.57% | -0.43% | Sep 2026 |
| Vanguard Institutional Index I | 4.22M | 0.53% | -1.40% | Sep 2026 |
| DWS Top Dividende LD | 4.10M | 0.52% | +0.00% | Sep 2026 |
| Vanguard High Dividend Yield ETF | 3.24M | 0.41% | +0.26% | Sep 2026 |
| T. Rowe Price Equity Income | 3.01M | 0.38% | +0.67% | Sep 2026 |
| Fidelity SAI US Quality Index | 2.88M | 0.36% | +2.64% | Sep 2026 |
| T. Rowe Price Dividend Growth | 2.77M | 0.35% | 0.00% | Sep 2026 |
| BNY Mellon Dynamic Value Fund A | 2.71M | 0.34% | -5.88% | Sep 2026 |
| Blackrock ACS NA ESG Insgts Eq X1 P Acc | 2.55M | 0.32% | +1.49% | Aug 2026 |
| CREF Total Global Stock Account R3 | 2.52M | 0.32% | +637.48% | Aug 2026 |
| State Street® SPDR® S&P® Dividend ETF | 2.51M | 0.32% | 0.00% | Oct 2026 |
Top institutions holding CL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 69.9M | 8.80% | -3.75% | Jun 2026 |
| Vanguard Capital Management, LLC | 52.2M | 6.57% | +0.05% | Jun 2026 |
| State Street Corp | 47.0M | 5.92% | -1.46% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 27.9M | 3.51% | -17.25% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 24.0M | 3.02% | +0.83% | Jun 2026 |
| Geode Capital Management, LLC | 23.1M | 2.91% | +1.07% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 22.1M | 2.78% | +5.71% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 16.4M | 2.06% | +102.19% | Jun 2026 |
| Bank of New York Mellon Corp | 13.5M | 1.70% | +8.07% | Jun 2026 |
| Deutsche Bank AG | 11.8M | 1.48% | -1.48% | Jun 2026 |
| NORGES BANK | 9.69M | 1.22% | -11.17% | Jun 2026 |
| Acadian Asset Management LLC | 9.10M | 1.14% | +14.61% | Jun 2026 |
| FMR Inc | 8.98M | 1.13% | -0.29% | Jun 2026 |
| The Goldman Sachs Group Inc | 8.57M | 1.08% | -9.55% | Jun 2026 |
| Northern Trust Corp | 8.47M | 1.07% | -2.41% | Jun 2026 |
| Amvescap Plc. | 8.33M | 1.05% | -0.16% | Jun 2026 |
| State Farm Mutual Automobile Ins Co | 6.73M | 0.85% | 0.00% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 6.47M | 0.81% | -5.24% | Jun 2026 |
| Amundi | 6.22M | 0.78% | +19.94% | Jun 2026 |
| Bank of America Corp | 6.19M | 0.78% | -6.75% | Jun 2026 |
Colgate-Palmolive Company company profile
- Company name
- Colgate-Palmolive Company
- Ticker
- CL.US
- Exchange
- USA Stocks
- Listed since
- Jan 3, 1977
- Sector
- Consumer Defensive
- Industry
- Household Products
- Employees
- 33,600
- Fiscal year end
- December
- Address
- 300 Park Avenue, New York, NY, United States, 10022-7499
- Phone
- 212 310 2000
- Website
- colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Colgate-Palmolive Company management
10- Mr. Noel R. WallaceChairman, CEO & President · born 1964
- Mr. Stanley J. Sutula IIIChief Financial Officer · born 1966
- Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health · born 1965
- Mr. Shane GrantChief Operating Officer of Americas · born 1975
- Mr. Stephan HabifChief Technology Officer
- Mr. David FosterChief Information Officer
- Ms. Betsy FishboneEVP, Chief Legal Officer & Secretary
- Mr. Eutychus KaruruExecutive Vice President of Internal Audit & Compliance
- Mr. Dana BoldenChief Communications Officer · born 1968
- Mr. Ram RaghavanChief Marketing Officer · born 1973